Familial Chylomicronemia Syndrome clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
Sorry, in progress, not accepting new patients
The purpose of the study is to evaluate the efficacy of Olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.
San Francisco, California and other locations